Tag: cb2r agonist

Study: Cannabinoids May Treat Newborn Brain Injury Caused by Germinal Matrix Hemorrhage

An important new study published by the National Institute of Health has found that activation of the endocannabinoid system – something done naturally by cannabinoids – can attenuate newborn brain injury caused by germinal matrix hemorrhages, which is one of the most common and devastating cerebrovascular events that affect premature infants. For the study, researchers …

Continue reading

Cannabis May Improve Outcome of Spinal Cord Injury, Finds Study

Activation of the body’s cannabinoid receptors – something done naturally by cannabis – can improve the outcome of spinal cord injury, according to a study published in the most recent issue (Volume 595, May, 2015) of the journal Neuroscience Letters. For the study, researchers “examined whether treatment with.. a selective synthetic cannabinoid receptor (CB1R) agonist, …

Continue reading

New Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection

A new study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print by the National Institute of Health, has found that cannabis may have immunosuppressive and anti-inflammatory properties, which may help treat a variety of conditions such as autoimmune diseases and graft rejection. According to researchers; “This …

Continue reading